Key laboratory markers include: IGF-1: Primary marker for sermorelin effectiveness and GH status Total and free testosterone: Evaluates TRT dosing adequacy Estradiol (E2): Monitors testosterone-to-estrogen conversion SHBG (sex hormone-binding globulin): Assesses bioavailable testosterone CBC/hematocrit: Monitors for TRT-related polycythemia PSA: Prostate screening for men on TRT Comprehensive metabolic panel: Liver function, kidney function, glucose metabolism Lipid panel: Cholesterol and triglyceride monitoring Hemoglobin A1c: Long-term glucose control assessment Labs are typically drawn at baseline, 6-8 weeks after initiation, and then every 3-6 months
1 Zaleplon, one of the first non-benzodiazepines developed for the treatment of insomnia, has been proven effective in reducing the amount of time it takes to fall asleep
However, new research suggests they may also carry potential risks related to bone health and gout, particularly when rapid weight loss occurs
C., Li, M., Schaak, D., Robson, D
It can lead to binge eating or a return to old habits that the medication was helping to suppress
)
